Lymphadenectomy in Urologic Oncology: Pathologic Considerations

Riley E. Alexander, Ming Tse Sung, Liang Cheng

Research output: Contribution to journalReview article

5 Scopus citations

Abstract

Lymphadenectomy (LAD) is an important staging and treatment modality of oncologic surgery. LAD in genitourinary malignancies presents inherent difficulties to the urologist and pathologist because of the differences in anatomic sites and primary histologic type. This review focuses on pathologic evaluation and how communication between urologist and pathologist is necessary to provide optimal care. Recommendations covering general specimen submission and processing are discussed, as well as more specific recommendations concerning the kidney, upper urinary tract, urinary bladder, prostate, testes, and penis. Emerging areas of prognostic significance and the impact that improved molecular techniques are contributing to diagnostic interpretation are highlighted.

Original languageEnglish (US)
Pages (from-to)483-495
Number of pages13
JournalUrologic Clinics of North America
Volume38
Issue number4
DOIs
StatePublished - Nov 1 2011

Keywords

  • Lymphadenectomy
  • Sampling and reporting
  • Staging and classification
  • Urinary bladder
  • Urothelial cancer

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Lymphadenectomy in Urologic Oncology: Pathologic Considerations'. Together they form a unique fingerprint.

  • Cite this